Alexion Pharmaceuticals, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/16/2021

Shares

996,173

Value ($000)

183,007

Weight

0.1%

2013 Q4 - 2021 Q2 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/16/2021	183,007	0.1%	996,173	6/30/2021
2021 Q1	5/14/2021	163,229	0.1%	1,067,481	3/31/2021
2020 Q4	3/1/2021	199,420	0.1%	1,276,371	12/31/2020
2020 Q3	11/13/2020	182,222	0.1%	1,592,433	9/30/2020
2020 Q2	8/14/2020	185,516	0.1%	1,652,848	6/30/2020
2020 Q1	5/15/2020	172,933	0.1%	1,925,969	3/31/2020
2019 Q4	2/14/2020	205,467	0.1%	1,899,838	12/31/2019
2014 Q1	5/23/2014	182,534	0.2%	1,199,855	3/31/2014
2013 Q4	1/31/2014	188,908	0.2%	1,419,725	12/31/2013